Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health
Rahul Banerjee, Nina Shah, Adam P. Dicker
JCO Clinical Cancer Informatics (2021), Iss. 5, pp. 668-678
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Feasibility, Acceptability, and Effectiveness of Electronic Patient-Reported Outcome Symptom Monitoring for Immune Checkpoint Inhibitor Toxicities: A Systematic Review
Julia Lai‐Kwon, Jordan E. Cohen, Karolina Lisy, et al.
JCO Clinical Cancer Informatics (2023), Iss. 7
Closed Access | Times Cited: 17
A proposed multi‐domain, digital model for capturing functional status and health‐related quality of life in oncology
Elena S. Izmailova, John A. Wagner, Jessie P. Bakker, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di, Christopher T. Su, Andrew J. Cowan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 10, pp. 1418-1429
Closed Access | Times Cited: 6
Applications of artificial intelligence multiomics in precision oncology
Ruby Srivastava
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 1, pp. 503-510
Closed Access | Times Cited: 22
Elaborating the potential of Artificial Intelligence in automated CAR-T cell manufacturing
Niklas Bäckel, Simon Hort, Tamás Kis, et al.
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 11
Developing alert thresholds and self-management advice for people receiving immune checkpoint inhibitors: a Multinational Association for Supportive Care in Cancer modified Delphi survey
Julia Lai‐Kwon, Claudia Rutherford, Stephanie Best, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Closed Access
Mapping immune checkpoint inhibitor side effects to item libraries for use in real-time side effect monitoring systems
Julia Lai‐Kwon, Michael Jefford, Stephanie Best, et al.
Journal of Patient-Reported Outcomes (2025) Vol. 9, Iss. 1
Open Access
Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable
Melissa Alsina, Binod Dhakal, Jeremy Pantin, et al.
Future Oncology (2025), pp. 1-8
Open Access
Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization
Laura B. Oswald, Xiaoyin Li, Rodrigo Carvajal, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2742-2742
Open Access | Times Cited: 18
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
Anne M. Spanjaart, Elise R. A. Pennings, Pim Mutsaers, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4334-4334
Open Access | Times Cited: 9
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Selecting Immune Checkpoint Inhibitor Side Effects for Real-Time Monitoring in Routine Cancer Care: A Modified Delphi Study
Julia Lai‐Kwon, Michael Jefford, Stephanie Best, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 12, pp. 1663-1675
Closed Access | Times Cited: 3
Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy
Alexander B. Brummer, Xin Yang, Eric Ma, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 1, pp. e1009504-e1009504
Open Access | Times Cited: 15
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Mobilizing CARs: Benefits, Drawbacks, and Directions for Outpatient CAR T-cell therapy
Jennifer S. Woo, Kim-Anh Nguyen, Lawrence Liu, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 273-283
Closed Access | Times Cited: 2
Innovation in BCMA CAR-T therapy: Building beyond the Model T
Rahul Banerjee, Sarah S. Lee, Andrew J. Cowan
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
Anne M. Spanjaart, Elise R. A. Pennings, Milan Kos, et al.
JCO Oncology Practice (2022) Vol. 19, Iss. 3, pp. e407-e416
Open Access | Times Cited: 8
Barriers to patient access of CAR T cell therapies in Austria
Georg Hopfinger, Bernhard Rupp, Richard Greil
memo - Magazine of European Medical Oncology (2023) Vol. 16, Iss. 1, pp. 79-90
Open Access | Times Cited: 4
Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review
Sally Taylor, Kate Law, Jake Coomber-Moore, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia
Lena E. Winestone, Deepa Bhojwani, Sara Ghorashian, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 56-70
Open Access | Times Cited: 3
Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy
Arpita Gandhi, Catherine J. Lee
Cancers (2023) Vol. 15, Iss. 16, pp. 4108-4108
Open Access | Times Cited: 2
Digital transformation of CAR-T cell therapy – challenges and potential for Industry 4.0
Simon Hort, Carmen Sanges, John J. L. Jacobs, et al.
Procedia CIRP (2023) Vol. 120, pp. 1034-1040
Open Access | Times Cited: 2
Reply to Z. Yin et al
Nico Gagelmann, Maximilian Merz
Journal of Clinical Oncology (2024) Vol. 42, Iss. 25, pp. 3064-3064
Closed Access
Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign?
Srishti Sankaran, Rahul Banerjee
JCO Clinical Cancer Informatics (2024), Iss. 8
Closed Access
Surgical decision-making in the digital age: the role of telemedicine – a narrative review
Shehla Parveen, Maryam Amjad, Sameer Abdul Rauf, et al.
Annals of Medicine and Surgery (2024) Vol. 87, Iss. 1, pp. 242-249
Open Access
Page 1 - Next Page

Scroll to top